Overview


According to FutureWise analysis the market for Animal Auto-Immune Disease Therapeutics in 2023 is US$ 43.36 billion, and is expected to reach US$ 66.64 billion by 2031 at a CAGR of 5.50%.

In Autoimmune disease, the body’s immune system starts attacking its cells and tissues. They usually occur due to low activity or excess immune system activity. It can happen in both humans as well as animals. About 80 types of autoimmune disease exist in humans. Various drugs other than therapies, such as surgeries and stem cell therapies, are used to treat autoimmune disease in animals. 

Animal Autoimmune disease therapeutics, also called veterinary autoimmune therapeutics, are the drugs administered in the animal’s body when the immune system does not work correctly and starts to attack the body’s tissues or organs. This disease can be primary and secondary. In primary condition, the cause is not identified. And secondary, in which the trigger, such as infections, cancer, or even certain medications, can be known. Some examples of such diseases are canine systemic lupus, pemphigus vulgaris, autoimmune haemolytic anaemia, etc. They are generally used to decrease symptoms, inflammation, and associated pain, inhibit the inappropriate immune response, and control the immunological response. Increasing the zoonotic disease transfer among humans can also cause a threat that needs to be controlled, and thus, the demand for this market is rising. 

FutureWise Market Research has published a report that provides an insightful analysis of Animal Autoimmune disease therapeutics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Animal Autoimmune disease therapeutics market twill experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Aratana Therapeutics Inc.
  • Pfizer Inc.
  • Vet-Stem, Inc.
  • Ambrx Inc.
  • Taconic Biosciences, Inc.
  • JBS United
  • Virbac
  • Eli Lilly and Company
  • Jaguar Animal Health Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The rise in the prevalence of animal autoimmune diseases is fuelling the market growth. Veterinary hospitals offer a wide range of therapeutic services for affected animals, boosting the demand for the growth of this market. More research and development efforts are made to provide the best possible treatments to the animals using therapeutics, creating new growth opportunities. Support from private and public organizations, creating more awareness and safety protocols for the animals, and providing them with care and proper treatment is a good initiative boosting the market growth. The availability of drugs, including tocilizumab, certolizumab, tofacitinib, and others, is prime support government should initiate and reach out to the maximum veterinary species that will drive the market growth. 

The use of innovative technologies and animal welfare legislation drives this industry. The industry is also fuelled by rising veterinary congenital disease knowledge and aiding them with the best possible drug treatments. However, some significant constraints are anticipated to restrain overall market growth to a certain extent over the projected period, including an absence of highly qualified veterinary researchers, limited therapy for animals in developing countries, and lack of awareness are hampering the market growth.

By Therapy Type

  • Corticosteroids
  • Azathioprine
  • Cyclosporine
  • Mycophenolate
  • Leflunomide
  • Cyclophosphamide
  • Levothyroxine
  • Folic Acid
  • Hydroxychloroquine
  • Chloroquine

By Disease Indication

  • Hypothyroidism
  • Pemphigus Disease
  • Canine Lupus
  • Auto-Immune Hemolytic Anemia
  • Bullous Pemphigoid
  • Discoid Lupus Erythematosus (DLE)
  • Immune-related arthritis
  • Others

By Animal Type

  • Companion Animal
    • Dogs
    • Cats
    • Horse
  • Live Stock Animal
    • Cattle
    • Swine
    • Poultry
    • Fish
    • Sheep

By Distribution Channel Type

  • Veterinary Hospitals
  • Veterinary Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America accounts for many companion animals, including cats, horses, and dogs. Day by day, the bond between the pets and the pet owner is increasing, which imbibes them for the pet’s health, increasing the market demand in this region. People nowadays treat their pets as their family members, which makes them focus more on the pet’s health, and a rise in care can be seen, which include them ineffective treatment and therapeutics, which is a driving factor for the market growth.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Animal Auto-Immune Disease Therapeutics Market By Therapy Type, By Disease Indication, By Animal Type, By Distribution Channel Type and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Animal Auto-Immune Disease Therapeutics Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Auto-Immune Disease Therapeutics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Animal Auto-Immune Disease Therapeutics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Animal Auto-Immune Disease Therapeutics Market, By Therapy Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Corticosteroids
        2. Azathioprine
        3. Cyclosporine
        4. Mycophenolate
        5. Leflunomide
        6. Cyclophosphamide
        7. Levothyroxine
        8. Folic Acid
        9. Hydroxychloroquine
        10. Chloroquine

  • 8.   Animal Auto-Immune Disease Therapeutics Market, By Disease Indication Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hypothyroidism
        2. Pemphigus Disease
        3. Canine Lupus
        4. Auto-Immune Hemolytic Anemia
        5. Bullous Pemphigoid
        6. Discoid Lupus Erythematosus (DLE)
        7. Immune-related arthritis
        8. Others

  • 9.   Animal Auto-Immune Disease Therapeutics Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Companion Animal
         1.1. Dogs
         1.2. Cats
         1.3. Horse
        2. Live Stock Animal
         2.1. Cattle
         2.2. Swine
         2.3. Poultry
         2.4. Fish
         2.5. Sheep

  • 10.   Animal Auto-Immune Disease Therapeutics Market, By Distribution Channel Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Veterinary Hospitals
        2. Veterinary Clinics

  • 11.   North America Animal Auto-Immune Disease Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Animal Auto-Immune Disease Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Animal Auto-Immune Disease Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Animal Auto-Immune Disease Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Aratana Therapeutics Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Pfizer Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Vet-Stem, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Ambrx Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Taconic Biosciences, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. JBS United
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Virbac
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Eli Lilly and Company
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Jaguar Animal Health Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11